0.684
3.66%
-0.026
Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | 0.675 |
Operating Expenses
|
45.79%
9.204
|
6.313 | 5.938 | 4.322 | 4.877 |
Interest Income/Expense |
5.26%
0.02
|
0.019 | 0.018 | 0.032 | 0.012 |
Operating Income/Loss |
45.79%
-9.204
|
-6.313 | -5.938 | -4.322 | -4.202 |
Income/Loss From Continuing Operations Before Tax |
-20.96
|
- | -4.333 | -3.838 | -14.57 |
Income/Loss From Continuing Operations After Tax |
168.83%
-20.96
|
-7.798 | -4.333 | -3.838 | -14.57 |
Net Income/Loss
|
168.83%
-20.96
|
-7.798 | -4.333 | -3.838 | -14.57 |
Preferred Stock Dividends And Other Adjustments |
0.208
|
- | 0.072 | 0.603 | 0.192 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
915.17%
34.91
|
3.4391 | 32.63 | 15.23 | 15.23 |
Diluted Average Shares |
915.17%
34.91
|
3.4391 | 32.63 | 15.23 | 15.23 |
Basic Earnings Per Share |
281.25%
-0.61
|
-0.16 | -0.13 | -0.29 | -0.97 |
Diluted Earnings Per Share |
281.25%
-0.61
|
-0.16 | -0.13 | -0.29 | -0.97 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.208
|
- | 0.072 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):